Inflammatory bowel disease events after exposure to interleukin 17 inhibitors secukinumab and ixekizumab

Postmarketing analysis from the RADAR (“Research on Adverse Drug events And Reports”) program

Kelsey A. Orrell, Morgan Murphrey, Ryan C. Kelm, Harrison H. Lee, David R. Pease, Anne E Laumann, Dennis P West, Beatrice Nardone*

*Corresponding author for this work

Research output: Contribution to journalArticle

7 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)777-778
Number of pages2
JournalJournal of the American Academy of Dermatology
Volume79
Issue number4
DOIs
StatePublished - Oct 1 2018

Fingerprint

LY2439821
Interleukin-17
Drug-Related Side Effects and Adverse Reactions
Inflammatory Bowel Diseases
Research
secukinumab

ASJC Scopus subject areas

  • Dermatology

Cite this

@article{ec9c26f27fa24995ba9e160bada3f335,
title = "Inflammatory bowel disease events after exposure to interleukin 17 inhibitors secukinumab and ixekizumab: Postmarketing analysis from the RADAR (“Research on Adverse Drug events And Reports”) program",
author = "Orrell, {Kelsey A.} and Morgan Murphrey and Kelm, {Ryan C.} and Lee, {Harrison H.} and Pease, {David R.} and Laumann, {Anne E} and West, {Dennis P} and Beatrice Nardone",
year = "2018",
month = "10",
day = "1",
doi = "10.1016/j.jaad.2018.06.024",
language = "English (US)",
volume = "79",
pages = "777--778",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Inflammatory bowel disease events after exposure to interleukin 17 inhibitors secukinumab and ixekizumab

T2 - Postmarketing analysis from the RADAR (“Research on Adverse Drug events And Reports”) program

AU - Orrell, Kelsey A.

AU - Murphrey, Morgan

AU - Kelm, Ryan C.

AU - Lee, Harrison H.

AU - Pease, David R.

AU - Laumann, Anne E

AU - West, Dennis P

AU - Nardone, Beatrice

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85053372309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053372309&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2018.06.024

DO - 10.1016/j.jaad.2018.06.024

M3 - Article

VL - 79

SP - 777

EP - 778

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 4

ER -